A SPAC formed two and a half years ago by outgoing Biogen chairman Stelios Papadopoulos will shutter without finding a deal. Tuesday after the market closed, Eucrates Biomedical Acquisition Corp. announced that it would hand money back to investors. Incorporated in August 2020, Eucrates set out to find a biomedical or healthcare company to bring onto the public markets amid a time when SPACs were all the rage in various tech spaces, electric vehicles, digital health and biotech.
Read the full article: SPAC Led by Biogen Chairman Papadopoulos Can’t Find a Deal and Will Liquidate //
Source: https://endpts.com/spac-led-by-biogen-chairman-papadopoulos-cant-find-a-deal-and-will-liquidate